[Overweight or obesity: impact on the results of the first IVF/ICSI attempt].

Surpoids ou obésité : influence sur les résultats de la première tentative de FIV/ICSI.

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
Historique:
received: 02 09 2020
pubmed: 24 1 2021
medline: 25 11 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

To evaluate the influence of overweight and obesity on the results of the first in vitro fertilization attempt, without or with intracytoplasmic microinjection (IVF/ICSI), in terms of live births. Retrospective observational study concerning the first IVF/ICSI attempts from 01/01/2006 to 31/12/2017 carried out at the Assisted Reproductive Technology of the CHU of Besançon, studying the delivery rate (excluding frozen embryos transfers), and the data of Assisted Reproductive Technology attempts, in overweight (BMI 25 to 29.9kg/m A total of 3192 patients were included. At the end of their first IVF/ICSI attempt, the delivery rate of women with standard BMI was 34.7%. The delivery rate was significantly lower in overweight women (29.5%, p=0.011) and comparable in obese women (32.4%, p=0.476). The birth rate of women with a BMI≥25 kg/m The delivery rate was lower in overweight women, whereas it was not significantly different in obese women.

Identifiants

pubmed: 33484901
pii: S2468-7189(21)00015-5
doi: 10.1016/j.gofs.2021.01.012
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

593-600

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

A Pithois (A)

Centre d'AMP, CHU Besançon, 25000 Besançon, France. Electronic address: alixanepithois@yahoo.fr.

C Mauppin (C)

Centre d'AMP, CHU Besançon, 25000 Besançon, France.

P Decaigny (P)

Centre d'AMP, CHU Besançon, 25000 Besançon, France.

G Tio (G)

Inserm CIC 1431, CHU Besançon, 25000 Besançon, France.

A Berdin (A)

Centre d'AMP, CHU Besançon, 25000 Besançon, France.

C Roux (C)

Centre d'AMP, CHU Besançon, 25000 Besançon, France; Inserm CIC 1431, CHU Besançon, 25000 Besançon, France.

J-B Pretalli (JB)

Centre d'AMP, CHU Besançon, 25000 Besançon, France; Inserm CIC 1431, CHU Besançon, 25000 Besançon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH